Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  oral complications
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 39 for your search:
Start Over
Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: Over 12
Sponsor: NCI, Other
Protocol IDs: 1001.00, FHCRC-1001.00, NCI-G01-2008, CDR0000068886, NCT00024037
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0537, CDR0000592644, NCT00656513
Phase III Randomized Study of Sucralfate Suspension vs Topical Vitamin E for the Treatment of Chemotherapy-Induced Mucositis
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1Z93, NCI-P94-0059
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Glutamine to Alleviate Stomatitis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/97)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-959251, NCI-P95-0069
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9709, CDR0000065912, NCI-P97-0121, NCT00003139
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9801, CDR0000066260, NCT00003313
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066687, NCCTG-969257, NCI-P98-0136, NCT00003610
Phase III Randomized Study of Nystatin in Patients Receiving High Dose Interleukin-2 (Summary Last Modified 07/2000)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 16 to 65
Sponsor: NCI
Protocol IDs: NCI-99-C-0097
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: RTOG-9901, CDR0000068406, NCI-P00-0177, NCT00008398
Phase III Randomized Study of Recombinant Human Keratinocyte Growth Factor in Reducing Therapy-Induced Oral Mucositis in Patients With Hematologic Malignancies Undergoing Total Body Irradiation and High-Dose Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0012064, AMGEN-KGF-20000162, FHCRC-1612.00, MSKCC-01065, NCI-G01-1961
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068810, P30CA016042, UCLA-0008049, IBP-PG-015, NCI-G01-2001, NCT00022373
Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069337, NCCTG-N01C4, NCI-P02-0224, N01C4, NCT00036881
Phase III Study of Chamomile Mouthwash for Stomatitis Prophylaxis in Patients Receiving 5-FU-Based Chemotherapy (Summary Last Modified 02/92)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-909256, MAYO-909256, NCI-P92-0001
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N09C6, NCI-2011-02049, CDR0000675520, U10CA037404, N09C6, NCT01156142
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 4 to 21
Sponsor: NCI, Other
Protocol IDs: ACCL1031, NCI-2011-02635, CDR0000695718, COG-ACCL1031, U10CA095861, NCT01305200
Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: 03-131, R21CA098792, P30CA008748, MSKCC-03131A, NCT00090337
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: RTOG-0022, CDR0000068231, RTOG-H-0022, RTOG-DEV-1065, NCT00006360
Phase II Study of Radioprotection of Oral and Pharyngeal Mucosa by the Prostaglandin E1 Analog Misoprostol (Summary Last Modified 07/1999)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9607, NCI-P97-0120, RTOG-96-07
Phase II Trial of G-CSF as an Oral Mucosal Protectant in Patients with Malignant Disease Receiving 5-FU plus Low-Dose CF
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UPCC-5990, NCI-T90-0163D, T90-0163
Phase II Randomized Study of RK-0202 to Prevent Radiotherapy-Induced Oral Mucositis in Patients With Tumors of the Oral Cavity, Oropharynx, Nasopharynx, Salivary Glands, or Supraglottic Region
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0205011, NCI-G02-2111, RK-0202:02, NCT00046956
Start Over